Medical Xpress January 18, 2025
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company’s bird flu vaccine, as fears of a new pandemic grow.
The funding will help Moderna “enhance mRNA platform capabilities so that the US is better prepared to respond to other emerging infectious diseases,” the Department of Health and Human Services (HHS) said in a statement.
The money “allows Moderna to accelerate development of an H5N1 mRNA influenza vaccine that is well matched to strains currently circulating in cows and birds.”
This is in addition to the $176 million Moderna was awarded in July 2024.
And on Thursday the US government announced $211 million in new funding for a...
Today's Sponsors
Today's Sponsor